Extra-nuclear effects of estrogen on cortical bone in males require ERαAF-1
Open Access
- 1 February 2017
- journal article
- research article
- Published by Bioscientifica in Journal of Molecular Endocrinology
- Vol. 58 (2) , 105-111
Abstract
Estradiol (E2) signaling via estrogen receptor alpha (ERα) is important for the male skeleton as demonstrated by ERα inactivation in both mice and man. ERα mediates estrogenic effects not only by translocating to the nucleus and affecting gene transcription but also by extra-nuclear actions e.g., triggering cytoplasmic signaling cascades. ERα contains various domains, and the role of activation function 1 (ERαAF-1) is known to be tissue specific. The aim of this study was to determine the importance of extra-nuclear estrogen effects for the skeleton in males and to determine the role of ERαAF-1 for mediating these effects. Five-month-old male wild-type (WT) and ERαAF-1-inactivated (ERαAF-10) mice were orchidectomized and treated with equimolar doses of 17β-estradiol (E2) or an estrogen dendrimer conjugate (EDC), which is incapable of entering the nucleus and thereby only initiates extra-nuclear ER actions or their corresponding vehicles for 3.5 weeks. As expected, E2 treatment increased cortical thickness and trabecular bone volume per total volume (BV/TV) in WT males. EDC treatment increased cortical thickness in WT males, whereas no effect was detected in trabecular bone. In ERαAF-10 males, E2 treatment increased cortical thickness, but did not affect trabecular bone. Interestingly, the effect of EDC on cortical bone was abolished in ERαAF-10 mice. In conclusion, extra-nuclear estrogen signaling affects cortical bone mass in males, and this effect is dependent on a functional ERαAF-1. Increased knowledge regarding estrogen signaling mechanisms in the regulation of the male skeleton may aid the development of new treatment options for male osteoporosis.Keywords
This publication has 32 references indexed in Scilit:
- Mediator of ERBB2-driven Cell Motility (MEMO) Promotes Extranuclear Estrogen Receptor Signaling Involving the Growth Factor Receptors IGF1R and ERBB2*Journal of Biological Chemistry, 2013
- The role of activation functions 1 and 2 of estrogen receptor-α for the effects of estradiol and selective estrogen receptor modulators in male miceJournal of Bone and Mineral Research, 2012
- Roles of transactivating functions 1 and 2 of estrogen receptor-α in boneProceedings of the National Academy of Sciences, 2011
- Oxidative Stress Stimulates Apoptosis and Activates NF-κB in Osteoblastic Cells via a PKCβ/p66shc Signaling Cascade: Counter Regulation by Estrogens or AndrogensMolecular Endocrinology, 2010
- GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male miceJournal of Bone and Mineral Research, 2010
- Non-nuclear estrogen receptor α signaling promotes cardiovascular protection but not uterine or breast cancer growth in miceJournal of Clinical Investigation, 2010
- The Estrogen Receptor-α in Osteoclasts Mediates the Protective Effects of Estrogens on Cancellous But Not Cortical BoneMolecular Endocrinology, 2010
- Novel actions of estrogen to promote proliferation: Integration of cytoplasmic and nuclear pathwaysSteroids, 2009
- The transactivating function 1 of estrogen receptor α is dispensable for the vasculoprotective actions of 17β-estradiolProceedings of the National Academy of Sciences, 2009
- Nuclear and Extranuclear Pathway Inputs in the Regulation of Global Gene Expression by Estrogen ReceptorsMolecular Endocrinology, 2008